Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048886549> ?p ?o ?g. }
- W3048886549 endingPage "409" @default.
- W3048886549 startingPage "404" @default.
- W3048886549 abstract "Objectives The pan-Canadian Oncology Drug Review (pCODR) evaluates new cancer drugs for public funding recommendations. While pCODR's deliberative framework evaluates overall clinical benefit and includes considerations for exceptional circumstances, rarity of indication is not explicitly addressed. Given the high unmet need that typically accompanies these indications, we explored the impact of rarity on oncology HTA recommendations and funding decisions. Methods We examined pCODR submissions with final recommendations from 2012 to 2017. Incidence rates were calculated using pCODR recommendation reports and statistics from the Canadian Cancer Society. Indications were classified as rare if the incidence rate was lower than 1/100,000 diagnoses, a definition referenced by the Canadian Agency for Drugs and Technologies in Health. Each pCODR final report was examined for the funding recommendation/justification, level of supporting evidence (presence of a randomized control trial [RCT]), and time to funding (if applicable). Results Of the ninety-six pCODR reviews examined, 16.6 percent were classified as rare indications per above criteria. While the frequency of positive funding recommendations were similar between rare and nonrare indication (78.6 vs. 75 percent), rare indications were less likely to be presented with evidence from RCT (50 vs. 90 percent). The average time to funding did not differ significantly across provinces. Conclusion Rare indications appear to be associated with weaker clinical evidence. There appears to be no association between rarity, positive funding recommendations, and time to funding. Further work will evaluate factors associated with positive recommendations and the real-world utilization of funded treatments for rare indications." @default.
- W3048886549 created "2020-08-18" @default.
- W3048886549 creator A5008282524 @default.
- W3048886549 creator A5020540368 @default.
- W3048886549 creator A5023439037 @default.
- W3048886549 creator A5025411824 @default.
- W3048886549 creator A5035467493 @default.
- W3048886549 creator A5038238109 @default.
- W3048886549 creator A5039283573 @default.
- W3048886549 creator A5047113165 @default.
- W3048886549 creator A5056959902 @default.
- W3048886549 creator A5063835785 @default.
- W3048886549 creator A5065891328 @default.
- W3048886549 creator A5070891561 @default.
- W3048886549 creator A5085932488 @default.
- W3048886549 date "2020-08-01" @default.
- W3048886549 modified "2023-10-12" @default.
- W3048886549 title "Impact of rarity on Canadian oncology health technology assessment and funding" @default.
- W3048886549 cites W1981248934 @default.
- W3048886549 cites W2098724822 @default.
- W3048886549 cites W2105845113 @default.
- W3048886549 cites W2145695460 @default.
- W3048886549 cites W2160488963 @default.
- W3048886549 cites W2170621602 @default.
- W3048886549 cites W2266111816 @default.
- W3048886549 cites W2266707907 @default.
- W3048886549 cites W2267333092 @default.
- W3048886549 cites W2520725128 @default.
- W3048886549 cites W2531558642 @default.
- W3048886549 cites W2600539686 @default.
- W3048886549 cites W2609146840 @default.
- W3048886549 cites W2621729744 @default.
- W3048886549 cites W2795700514 @default.
- W3048886549 cites W2796659008 @default.
- W3048886549 cites W2895900438 @default.
- W3048886549 cites W2915627787 @default.
- W3048886549 cites W2946967649 @default.
- W3048886549 cites W2954640182 @default.
- W3048886549 cites W2100722016 @default.
- W3048886549 doi "https://doi.org/10.1017/s0266462320000483" @default.
- W3048886549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32779560" @default.
- W3048886549 hasPublicationYear "2020" @default.
- W3048886549 type Work @default.
- W3048886549 sameAs 3048886549 @default.
- W3048886549 citedByCount "1" @default.
- W3048886549 countsByYear W30488865492022 @default.
- W3048886549 crossrefType "journal-article" @default.
- W3048886549 hasAuthorship W3048886549A5008282524 @default.
- W3048886549 hasAuthorship W3048886549A5020540368 @default.
- W3048886549 hasAuthorship W3048886549A5023439037 @default.
- W3048886549 hasAuthorship W3048886549A5025411824 @default.
- W3048886549 hasAuthorship W3048886549A5035467493 @default.
- W3048886549 hasAuthorship W3048886549A5038238109 @default.
- W3048886549 hasAuthorship W3048886549A5039283573 @default.
- W3048886549 hasAuthorship W3048886549A5047113165 @default.
- W3048886549 hasAuthorship W3048886549A5056959902 @default.
- W3048886549 hasAuthorship W3048886549A5063835785 @default.
- W3048886549 hasAuthorship W3048886549A5065891328 @default.
- W3048886549 hasAuthorship W3048886549A5070891561 @default.
- W3048886549 hasAuthorship W3048886549A5085932488 @default.
- W3048886549 hasConcept C108170787 @default.
- W3048886549 hasConcept C111472728 @default.
- W3048886549 hasConcept C120665830 @default.
- W3048886549 hasConcept C121332964 @default.
- W3048886549 hasConcept C126322002 @default.
- W3048886549 hasConcept C138885662 @default.
- W3048886549 hasConcept C168563851 @default.
- W3048886549 hasConcept C512399662 @default.
- W3048886549 hasConcept C61511704 @default.
- W3048886549 hasConcept C71924100 @default.
- W3048886549 hasConceptScore W3048886549C108170787 @default.
- W3048886549 hasConceptScore W3048886549C111472728 @default.
- W3048886549 hasConceptScore W3048886549C120665830 @default.
- W3048886549 hasConceptScore W3048886549C121332964 @default.
- W3048886549 hasConceptScore W3048886549C126322002 @default.
- W3048886549 hasConceptScore W3048886549C138885662 @default.
- W3048886549 hasConceptScore W3048886549C168563851 @default.
- W3048886549 hasConceptScore W3048886549C512399662 @default.
- W3048886549 hasConceptScore W3048886549C61511704 @default.
- W3048886549 hasConceptScore W3048886549C71924100 @default.
- W3048886549 hasIssue "4" @default.
- W3048886549 hasLocation W30488865491 @default.
- W3048886549 hasLocation W30488865492 @default.
- W3048886549 hasOpenAccess W3048886549 @default.
- W3048886549 hasPrimaryLocation W30488865491 @default.
- W3048886549 hasRelatedWork W1580426574 @default.
- W3048886549 hasRelatedWork W1970383787 @default.
- W3048886549 hasRelatedWork W2043123170 @default.
- W3048886549 hasRelatedWork W2089620537 @default.
- W3048886549 hasRelatedWork W2275480158 @default.
- W3048886549 hasRelatedWork W3095306390 @default.
- W3048886549 hasRelatedWork W3209251735 @default.
- W3048886549 hasRelatedWork W4238089809 @default.
- W3048886549 hasRelatedWork W4241346791 @default.
- W3048886549 hasRelatedWork W4256514411 @default.
- W3048886549 hasVolume "36" @default.
- W3048886549 isParatext "false" @default.
- W3048886549 isRetracted "false" @default.